TVRD 8-K 2026-07-17

Tvardi Therapeutics, Inc. (TVRD) 8-K dated 2026-07-17 — accession 0001104659-26-084627. This URL is the filing, not the TVRD hub.

Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.

Tvardi Therapeutics, Inc. filed a 8-K on 2026-07-17. Accession 0001104659-26-084627.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $10.0M.

Not investment advice. The TVRD SEC hub lists recent forms. The stock page is the research view.